The activation of astrocytes also modifies protein expression, including the glial fibrillary acidic protein (GFAP) and chitinase-3-like protein 1 (YKL-40), both soluble astrocytic markers typically measured in patients with AD. This evidence concerns the gene GFAP and Alzheimer disease.